Clinical factors associated with lithium response in bipolar disorders

Autor: Pierre A. Geoffroy, Sébastien Gard, Clara Brichant-Petitjean, Jean-Michel Azorin, Chantal Henry, Sarah Sportiche, Marion Leboyer, Bruno Etain, Jan Scott, Jean Pierre Khan, Frank Bellivier

Publikováno v: Australian and New Zealand Journal of Psychiatry
Australian and New Zealand Journal of Psychiatry, 2017, 51 (5), pp.524-530. ⟨10.1177/0004867416664794⟩
Australian and New Zealand Journal of Psychiatry, SAGE Publications, 2017, 51 (5), pp.524-530. ⟨10.1177/0004867416664794⟩

Background: Bipolar disorder is a common chronic illness characterized by high levels of morbidity and all-cause mortality. Lithium is one of the gold standard mood stabilizer treatments, but the identification of good, partial and non-responders in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291705d7692aa0b9f05839ffe2395ce0
https://pubmed.ncbi.nlm.nih.gov/27557821